OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
	211
Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database	100
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	97
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	87
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas	80
Evaluation of an artificial intelligence support system for breast cancer screening in Chinese people based on mammogram	70
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis	70
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age–period–cohort modeling study	69
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	64
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	62
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China	62
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	59
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APC^min^/+‐induced colorectal cancer	59
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer	58
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	57
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	56
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	55
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	53
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	51
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	49
Characteristics of anal canal cancer in Japan	48
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	48
The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations	47
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	47
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	47

Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer	45
Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta‐analysis	45
Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer	44
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	43
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics	42
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors	42
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells	42
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements	42
Health‐related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma	41
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	40
SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer	40
Family physicians' involvement in palliative cancer care	40
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	39
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer	39